145 related articles for article (PubMed ID: 15345319)
21. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin.
Takahashi T; Ohno O; Ikeda Y; Sawa R; Homma Y; Igarashi M; Umezawa K
J Antibiot (Tokyo); 2006 Jan; 59(1):35-43. PubMed ID: 16568717
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of endotoxin by human plasma gelsolin.
Bucki R; Georges PC; Espinassous Q; Funaki M; Pastore JJ; Chaby R; Janmey PA
Biochemistry; 2005 Jul; 44(28):9590-7. PubMed ID: 16008344
[TBL] [Abstract][Full Text] [Related]
24. Structural investigations into the interaction of hemoglobin and part structures with bacterial endotoxins.
Howe J; Garidel P; Roessle M; Richter W; Alexander C; Fournier K; Mach JP; Waelli T; Gorczynski RM; Ulmer AJ; Zähringer U; Hartmann A; Rietschel ET; Brandenburg K
Innate Immun; 2008 Feb; 14(1):39-49. PubMed ID: 18387918
[TBL] [Abstract][Full Text] [Related]
25. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
[TBL] [Abstract][Full Text] [Related]
26. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor.
Hoess A; Schneider-Mergener J; Liddington RC
Prog Clin Biol Res; 1995; 392():327-37. PubMed ID: 8524938
[No Abstract] [Full Text] [Related]
27. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
Rosenfeld Y; Sahl HG; Shai Y
Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
[TBL] [Abstract][Full Text] [Related]
28. The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides.
David SA; Awasthi SK; Balaram P
J Endotoxin Res; 2000; 6(3):249-56. PubMed ID: 11052180
[TBL] [Abstract][Full Text] [Related]
29. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
[TBL] [Abstract][Full Text] [Related]
30. The specificity of Sushi peptides for endotoxin and anionic phospholipids: potential application of POPG as an adjuvant for anti-LPS strategies.
Li P; Sun M; Ho B; Ding JL
Biochem Soc Trans; 2006 Apr; 34(Pt 2):270-2. PubMed ID: 16545091
[TBL] [Abstract][Full Text] [Related]
31. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14.
Iwagaki A; Porro M; Pollack M
Infect Immun; 2000 Mar; 68(3):1655-63. PubMed ID: 10678985
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.
Bhunia A; Mohanram H; Bhattacharjya S
Biopolymers; 2009; 92(1):9-22. PubMed ID: 18844294
[TBL] [Abstract][Full Text] [Related]
33. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A.
Jürgens G; Müller M; Garidel P; Koch MH; Nakakubo H; Blume A; Brandenburg K
J Endotoxin Res; 2002; 8(2):115-26. PubMed ID: 12028751
[TBL] [Abstract][Full Text] [Related]
34. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases.
Vallespi MG; Glaria LA; Reyes O; Garay HE; Ferrero J; Araña MJ
Clin Diagn Lab Immunol; 2000 Jul; 7(4):669-75. PubMed ID: 10882670
[TBL] [Abstract][Full Text] [Related]
35. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
[TBL] [Abstract][Full Text] [Related]
36. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity.
Li P; Ho B; Ding JL
J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557
[TBL] [Abstract][Full Text] [Related]
37. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells.
Gutsmann T; Howe J; Zähringer U; Garidel P; Schromm AB; Koch MH; Fujimoto Y; Fukase K; Moriyon I; Martínez-de-Tejada G; Brandenburg K
Innate Immun; 2010 Feb; 16(1):39-47. PubMed ID: 19567486
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
[TBL] [Abstract][Full Text] [Related]
39. The interaction of arginine- and tryptophan-rich cyclic hexapeptides with Escherichia coli membranes.
Junkes C; Wessolowski A; Farnaud S; Evans RW; Good L; Bienert M; Dathe M
J Pept Sci; 2008 Apr; 14(4):535-43. PubMed ID: 17985396
[TBL] [Abstract][Full Text] [Related]
40. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia.
Roth RI; Su D; Child AH; Wainwright NR; Levin J
J Infect Dis; 1998 Feb; 177(2):388-94. PubMed ID: 9466526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
